Case report presents compound heterozygous mutations decreasing factor XI activity in an elderly male, suggesting implications for treatment.
Because both gene mutations were heterozygous, the patient had compound heterozygous mutations that decreased FXI activity. J. Med. Invest. 73 : 281-285, February, 2026.
No takes yet. Share an insight, caveat, or question.
Sugasaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: